GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx digital pill ID-Cap™ System. Standley’s onboarding aligns with recent etectRx partnerships with other digital health providers working toward providing solutions for medication adherence.
Standley is a Brown University graduate in aerospace engineering, innovation management and entrepreneurship. He brings a deep background in product development for drug delivery, biosensing, and combination products to etectRx. As vice president of product management, he will chart the course for the FDA cleared ID-Cap System that uniquely addresses the issue of patient adherence to oral medication and allows clinicians to monitor medication adherence remotely. He enters etectRx as the company explores the importance of utilizing its technology in Use Cases to unequivocally confirm adherence for pharma clinical trial success. He will also be tasked with ensuring seamless ID-Cap System data management and integration across the healthcare ecosystem.
Prior to joining etectRx, Standley served as the senior director of product development for biotech company Windgap Medical, Inc. In this role, Standley led the design and development of a novel combination product and secured a contract with the National Institute of Health to develop a cyanide antidote autoinjector. He spearheaded development of a global supply chain for cGMP device and drug manufacturing, including injection molding, assembly, drug sourcing, and powder and liquid fill-finish of a combination product. Standley’s early career focused on developing advanced materials for startups in applications ranging from photovoltaic energy harvesting and nanowire battery technologies, to wearable electronics for biosensing applications.
“Adam’s wealth of knowledge in working with novel digital health systems is going to benefit the team here at etectRx,” said Valerie Sullivan, president and CEO of etectRx. “He is going to play a crucial role in the adoption of the ID-Cap System into the pharma ecosystem as he works to deliver innovative results through our various clinical trials and partnerships. His experience in mechanical and signal processing will help take the ID-Cap System to the next level as we partner with other digital health providers and pharma companies.”
Standley is set to join the team March 1, 2021.
etectRx is a digital health company. The FDA cleared ID-Cap System uniquely addresses the issue with patient adherence to (oral) medication. The accurate, flexible and elegant digital pill system allows pharmaceutical companies to rethink approaches to medication adherence, innovate with confidence, and accelerate patient outcomes. To learn more about etectRx, visit https://etectrx.com/.
Media Contact for etectRx™
Findsome & Winmore